Hewes L. Becker — SEC Form 4 filings
SEC reporting owner CIK 1840110. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-07.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-06 to 2026-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 4 filings — 54,646 shares, $5,562,136 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 20,904 shares @ $105.81 ($2,211,852) in Blueprint Medicines Corp, filed 2024-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Chief Medical Officer | 7 | — | 11 legs · 54,646 sh · $5,562,136 | 19 |
| Galecto, Inc. (GLTO) | Chief Medical Officer | 1 | — | — | 2 |
Form 4 filings — Hewes L. Becker
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-07 | 4 | Galecto, Inc. (GLTO) | Grant/award (A): 264,629 @ $0 · Grant/award (A): 528,603 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 21,353 · Disposition to issuer (D): 50,165 · Code (U): 1,607 · Disposition to issuer (D): 13,490 (derivative) · Disposition to issuer (D): 26,125 (derivative) · Disposition to issuer (D): 9,115 (derivative) · +3 more | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 4,863 @ $88.80 · Sale (S): 2,691 @ $87.42 · Sale (S): 2,541 @ $87.98 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 11,000 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,424 @ $104.91 | EDGAR |
| 2024-06-04 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 10,573 @ $66.24 · Option exercise (M): 8,385 @ $61.31 · Option exercise (M): 5,729 @ $43.15 · Sale (S): 3,671 @ $107.86 · Sale (S): 3,191 @ $106.50 · Sale (S): 20,904 @ $105.81 · +6 more | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 3,097 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840110 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →